Immunophenotyping at the time of diagnosis distinguishes two groups of nasopharyngeal carcinoma patients: implications for adoptive immunotherapy.
about
Understanding the interplay between host immunity and Epstein-Barr virus in NPC patientsTumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma.Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersTargeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma.Ex vivo expansion of tumor-infiltrating lymphocytes from nasopharyngeal carcinoma patients for adoptive immunotherapyTherapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma.Annexin A2-mediated cancer progression and therapeutic resistance in nasopharyngeal carcinoma.
P2860
Q26823898-E1F34728-1404-4355-BB7C-A636E502225EQ34221714-BF639FAD-D1DE-44B5-A0C5-35512B633C92Q35738744-AC588120-8805-4AC9-BC20-F37A9C55BB61Q36413665-D15D89B1-19E6-4986-A197-67F225C5750DQ37183682-5A6E3866-5116-4B80-87DB-EF044246DEF5Q37195079-C819F571-1DC3-406A-9A22-092376B2E1BEQ53700212-14E5BDB9-5768-4254-80B2-5E715C5BFD8E
P2860
Immunophenotyping at the time of diagnosis distinguishes two groups of nasopharyngeal carcinoma patients: implications for adoptive immunotherapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Immunophenotyping at the time ...... ns for adoptive immunotherapy.
@ast
Immunophenotyping at the time ...... ns for adoptive immunotherapy.
@en
type
label
Immunophenotyping at the time ...... ns for adoptive immunotherapy.
@ast
Immunophenotyping at the time ...... ns for adoptive immunotherapy.
@en
prefLabel
Immunophenotyping at the time ...... ns for adoptive immunotherapy.
@ast
Immunophenotyping at the time ...... ns for adoptive immunotherapy.
@en
P2093
P2860
P356
P1476
Immunophenotyping at the time ...... ns for adoptive immunotherapy.
@en
P2093
Haoyuan Mo
Qiu-yan Chen
Yi-lan Zhang
Yi-xin Zeng
Zhou-feng Huang
P2860
P304
P356
10.7150/IJBS.7.607
P407
P577
2011-05-18T00:00:00Z